Lupin share news, announcements and annual reports
NSE: LUPINBSE: 500257Pharmaceuticals & BiotechnologyMid Cap
Lupin Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 1993 on BSE, Sep 2001 on NSE
Last close ₹1,989.90up ₹17.20 (0.87%)BSE ₹1,998.00
Share price at the NSE close on 29 Oct 2026. Previous close ₹1,972.70.
29 Oct: open ₹1,977.40, high ₹1,999.60, low ₹1,962.30
52-week range of traded prices to 29 Oct 2026
₹1,892.90Low, 23 Oct 2026₹2,529.50High, 16 Jul 2026
- Next results date: the board meets on 3 Nov 2026 to consider: financial results and other business matters. The notice · Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹90,996 Cr105th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 16.46
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹558 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 14.95
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 4.05
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.90%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 27.9%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes −₹558 crore of one-off items, the largest of them in the quarter to Dec 2025.
- 30.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 28.2%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.26
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 7,81,45154.5% delivered
Lupin share news and announcements
2,113 announcements, routine notices left out, newest first. Page 41 of 43.
Oct 2008
8 Oct · Management
At the meeting of the Board of Directors held on October 08, 2008, the following decisions were taken: a) Dr. Kamal K. Sharma was re-appointed as Managing Director of the Company for a period of four years w.e.f. September 29, 2008. 2) Mr. Nilesh Gupta was appointed as Additional Director of the Company w.e.f. October 08, 2008 and is designated, Executive Director.
Sep 2008
24 Sep · Disclosure
Summary of Continual Disclosure of Shareholding in the Company pursuant to Clause 13 of SEBI (Prohibition of Insider Trading) Regulations, 1992. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.22 Sep · Allotment of Equity Shares
Allotment Committee of Directors at its meeting held on September 22, 2008 has allotted 40531 fully paid up equity shares of Rs. 10/- each. These shares have been allotted upon exercising of options granted to the employees under the Stock Option Plans of the Company. In view of the above, the issued and paid up capital of the Company increased to Rs. 822,944,060 consisting 82,294,406 equity shares of Rs. 10/- each.18 Sep · Business
Press release dated September 18, 2008, titled " Lupin in Equity Partnership with Pharma Dynamics, South Africa". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Aug 2008
25 Aug · Disclosure
Summary of Continual Disclosure of Shareholding in the Company. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.25 Aug · Disclosure
Summary of Continual Disclosure of Shareholding in the Company of Dr. D. B. Gupta. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.21 Aug · Business
Press release dated August 21, 2008, titled "Lupin Acquires Stake in Generic Health, Australia ". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.20 Aug · Allotment of Equity Shares
Allotment Committee of Directors at its meeting held on August 20, 2008 has allotted 1,17,573 fully paid up equity shares of Rs. 10/- each, the particulars of which are as under:- 1) Issue of shares upon conversion of Zero Coupon Foreign Currency Convertible Bonds (FCCB) issued by the Company pursuant to the Offering Memorandum dated January 2, 2006 and the number of shares are 81581. 2) Issue of shares upon exercising the options granted to employees under the stock option plans of the Company and the number of shares are 35992. In view of the above, the issued and paid up capital of the Company increased to Rs. 822,538,750 consisting 82,253,875 equity shares of Rs. 10/- each.19 Aug · Business
Press release dated August 19, 2008, titled "Lupin Enters into a Marketing Alliance with Forest Laboratories, Inc for AeroChamber Plus(R) Brand in the US ". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.14 Aug · Disclosure
Information in respect of change in holdings of Equity Shares of Rs.10/- each in the Company, of Officer(s), of the Company and their Dependent Family Members. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2008
31 Jul · Grant of Options
The Company has granted 25000 options under Lupin Employees Stock Option Plan 2003 and 17820 Options under Lupin Employees Stock Option Plan 2005 to its employees at the exercise price of Rs.719.45 on July 30, 2008. Please note that one equity share of Rs.10/- each is covered by each option. The options issued are exercisable at the 'market price' as defined in SEBI guidelines, in a phased manner after a minimum vesting period of 12 months but before the exercise period of 10 years from the date of grant31 Jul · Business
Press release dated July 31, 2008, titled "Lupin receives USFDA approval for Divalproex Sodium Delayed-Release Tablets". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.30 Jul · Business
Press release dated July 30, 2008, titled "Lupin Makes an Acquisition in Germany". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.30 Jul · Disclosure
In terms of the clause 13 - Continual Disclosures in terms of the provisions of the SEBI ( Prohibition of Insider Trading) Regulation, 1992, in respect of change in holdings of Equity Shares of Rs.10/- each in the Company, of Officer(s), of the Company. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.25 Jul · Allotment of Equity Shares
The Allotment Committee of Directors at its meeting held on July 25, 2008 has allotted 48605 fully paid up equity shares of Rs.10/- each. These shares have been allotted upon exercising of options granted to the employees under the Stock Option Plans of the Company. In view of the above, the issued and paid up capital of the Company increased to Rs.821,363,020 consisting 82,136,302 equity shares of Rs.10/- each22 Jul · Business
Press release dated July 22, 2008, titled "Lupin Q1, FY08-09 Consolidated Net Profit up 101% to Rs.1120 Mn, Sales at Rs 8792 Mn up by 49%". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.22 Jul · Results
Standalone Results for the quarter ended on 30-JUN-2008 as follows: Net Sales of Rs. 71242 lacs for quarter ending on 30-JUN-2008 against Rs. 60175 lacs for the quarter ending on 30-JUN-2007. Net Profit / (Loss) of Rs. 10852 lacs for the quarter ending on 30-JUN-2008 against Rs. 7838 lacs for the quarter ending on 30-JUN-2007.22 Jul · Results
Consolidated Results for the quarter ended on 30-JUN-2008 as follows: Net Sales of Rs. 86232 lacs for quarter ending on 30-JUN-2008 against Rs. 57573 lacs for the quarter ending on 30-JUN-2007. Net Profit / (Loss) of Rs. 11204 lacs for the quarter ending on 30-JUN-2008 against Rs. 5588 lacs for the quarter ending on 30-JUN-2007.7 Jul · Board meeting
Meeting on 22 Jul 2008: “Unaudited Financial Results for the Qtr ended June 30, 2008”3 Jul · Updates
Lupin Limited had informed the Exchange regarding the dates of Book Closure and the Annual General Meeting of the Company. The Company has made arrangements for the payment of dividend within stipulated period subject to approval of the shareholders, at the ensuing Annual General Meeting held on July 22, 2008. The dividend shall be remitted through ECS for specified centers, wherever the prescribed bank details has been provided by the shareholders. However, wherever the bank account particulars of the shareholders are not available with the Company, the dividend shall be issued through warrants payable at par, at centers mentioned in attached list, drawn on the Company's bankers viz "Citi Bank N.A.", with correspondent bank "Axis Bank". The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/CorporateAnnouncements). For more details click here.
Jun 2008
26 Jun · Business
Press release dated June 26, 2008, titled "Lupin appoints New NCE Research Head". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.25 Jun · Meeting
Annual General Meeting of the Company will be held on July 22, 2008. Further the Board of Directors at their meeting held on May 14, 2008, have decided to close the Register of Members and Share Transfer Register from July 15, 2008 to July 22, 2008 (both days inclusive) for the purpose of Annual General Meeting and Dividend.23 Jun · Business
Press release dated June 23, 2008, titled "Lupin Enters Into Marketing Alliance with Ascend Therapeutics for SUPRAX(R) 400mg Tablets in the U.S.". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.16 Jun · Business
Press release dated June 16, 2008, titled "Lupin receives USFDA approval for Escitalopram Oxalate Tablets". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.12 Jun · Business
Press release dated June 11, 2008, titled "Lupin launches Ramipril capsules in the US". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.12 Jun · Allotment of Equity Shares
The Allotment Committee of Directors at its meeting held on June 12, 2008 has allotted 6802 fully paid up equity shares of Rs.10/- each. These shares have been allotted upon exercising of options granted to the employees under the Stock Option Plans of the Company. In view of the above, the issued and paid up capital of the Company increased to Rs. 820,876,970 consisting 82,087,697 equity shares of Rs. 10/- each
May 2008
30 May · Business
Press release dated May 30, 2008, titled "Lupin receives USFDA Approval for Topiramate Tablets". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.14 May · Business
Press release dated May 14, 2008, titled "Lupin FY 2007-08 Consolidated Net Profit up 32% to Rs.4083 mn". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.14 May · Results
Consolidated Results for the year ended on 31-MAR-2008 as follows: Net Sales of Rs. 270637 lacs for year ending on 31-MAR-2008 against Rs. 201371 lacs for the year ending on 31-MAR-2007. Net Profit / (Loss) of Rs. 40825 lacs for the year ending on 31-MAR-2008 against Rs. 30856 lacs for the year ending on 31-MAR-2007.14 May · Results
Consolidated Results for the quarter ended on 31-MAR-2008 as follows: Net Sales of Rs. 75038 lacs for quarter ending on 31-MAR-2008 against Rs. 53183 lacs for the quarter ending on 31-MAR-2007. Net Profit / (Loss) of Rs. 9587 lacs for the quarter ending on 31-MAR-2008 against Rs. 14114 lacs for the quarter ending on 31-MAR-2007.14 May · Results
Standalone Results for the year ended on 31-MAR-2008 as follows: Net Sales of Rs. 254369 lacs for year ending on 31-MAR-2008 against Rs. 197093 lacs for the year ending on 31-MAR-2007. Net Profit / (Loss) of Rs. 44338 lacs for the year ending on 31-MAR-2008 against Rs. 30206 lacs for the year ending on 31-MAR-2007.14 May · Results
Standalone Results for the quarter ended on 31-MAR-2008 as follows: Net Sales of Rs. 61957 lacs for quarter ending on 31-MAR-2008 against Rs. 51806 lacs for the quarter ending on 31-MAR-2007. Net Profit / (Loss) of Rs. 7664 lacs for the quarter ending on 31-MAR-2008 against Rs. 13708 lacs for the quarter ending on 31-MAR-2007.14 May · Dividend
Board of Directors of the Company at its meeting held on May 14, 2008 has recommended dividend @ 100% i.e. Rs.10/- per equity share of the face value of Rs.10/- each (including a special dividend @50% i.e.Rs.5/- per equity share) for the year ended March 31, 2008.
Apr 2008
30 Apr · Management
Mr. Kiran N. Bade, Company Secretary & Compliance Officer, has resigned from the services of the Company w.e.f. May 01, 2008 and Mr. R.V. Satam has been appointed in his place28 Apr · Business
Press release dated April 28, 2008, titled "Lupin Launches SUPRAX 400 mg Tablets in the US". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.25 Apr · Board meeting
Inter alia, to consider the audited accounts for the year ended March 31, 2008 and recommend dividend, if any.23 Apr · Business
Press release dated April 23, 2008, titled "Lupin expands its product basket in Japan; Kyowa receives Ten product approvals". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.9 Apr · Results
The last accounting year of the Company ended on March 31, 2008 and we intend to finalise and publish the audited results for the said year within the time stipulated by Clause 41 of the Listing Agreement. In view of the above, publication of the unaudited results for the last quarter i.e. January 01, 2008 to March 31, 2008 would not be necessary.8 Apr · Rating
ICRA Limited has assigned "A1+" (pronounced "A one plus") rating to the Company's bank limit for Fund based/Non-Fund based facilities aggregating Rs.7000 million. This rating is the highest credit quality rating assigned by ICRA for the short term
Feb 2008
20 Feb · Allotment of Equity Shares
The Allotment Committee of Directors at its meeting held on February 20, 2008 has allotted 9474 fully paid up equity shares of Rs.10/- each. These shares have been allotted upon exercising of options granted to the employees under the Stock Option Plans of the Company. In view of the above, the issued and paid up capital of the Company increased to Rs. 820,808,950 consisting 82,080,895 equity shares of Rs. 10/- each
Jan 2008
24 Jan · Grant of Stock Options
The Company has granted 21000 options under Lupin Employees Stock Option Plan 2003 and 49020 Options under Lupin Employees Stock Option Plan 2005 to its employees at the exercise price of Rs.535.50 on January 22, 2008. Please note that one equity share of Rs.10/- each is covered by each option. The options issued are exercisable at the 'market price' as defined in SEBI guidelines, in a phased manner after a vesting period of minimum 12 months but before the exercise period of 10 years from the date of grant22 Jan · Business
Press release dated January 22, 2008, titled "Lupin Q3 FY0708 Consolidated Net Profit up 192% to Rs. 1809 Mn". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.22 Jan · Results
Consolidated Results for the quarter ended on 31-DEC-2007 as follows: Net Sales of Rs. 72129 lacs for quarter ending on 31-DEC-2007 against Rs. 50543 lacs for the quarter ending on 31-DEC-2006. Net Profit / (Loss) of Rs. 18086 lacs for the quarter ending on 31-DEC-2007 against Rs. 6202 lacs for the quarter ending on 31-DEC-2006.22 Jan · Results
Standalone Results for the quarter ended on 31-DEC-2007 as follows: Net Sales of Rs. 60805 lacs for quarter ending on 31-DEC-2007 against Rs. 49671 lacs for the quarter ending on 31-DEC-2006. Net Profit / (Loss) of Rs. 17028 lacs for the quarter ending on 31-DEC-2007 against Rs. 5603 lacs for the quarter ending on 31-DEC-2006.22 Jan · Management
Dr. Vijay Kelkar has ceased to be a Director of the Company w.e.f. December 31, 2007. The President of India has constituted the Finance Commission under the Chairmanship of Dr. Kelkar, who has assumed its charge on January 1, 2008. Considering the nature of his office, Dr. Kelkar has decided to withdraw from all his Directorships11 Jan · Board meeting
Meeting on 22 Jan 2008: “Unaudited Financial Results for the qtr ended Dec 31, 2007”8 Jan · Allotment of Equity Shares
The Allotment Committee of Directors at its meeting held on January 08, 2008 has allotted 11997 fully paid up equity shares of Rs. 10/- each. These shares have been allotted upon exercising of options granted to the employees under the Stock Option Plans of the Company. In view of the above, the issued and paid up capital of the Company increased to Rs. 820,714,210 consisting 82,071,421 equity shares of Rs. 10/- each
Nov 2007
30 Nov · Allotment of Equity Shares
The Allotment Committee of Directors at its meeting held on November 30, 2007 has allotted 6030 fully paid up equity shares of Rs. 10/- each. These shares have been allotted upon exercising of options granted to the employees under the Stock Option Plans of the Company. In view of the above, the issued and paid up capital of the Company increased to Rs. 820,594,240 consisting 82,059,424 equity shares of Rs. 10/- each.16 Nov · Results
Report, considering Postal Ballot forms received up to the close of working hours on November 15, 2007 was submitted by the Scrutinizer to the Chairman and the result of the Postal Ballot was announced on November 16, 2007. As per the said results, 44,027,842 votes were cast in favour of the Special Resolution and 9,515 votes against it. The Special Resolution was accordingly passed by Special majority.14 Nov · Business
Press release dated November 13, 2007, titled "Lupin gets new Pharmaceutical Research Head". A copy of the press release shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.